Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Oligodendrocyte
100%
Demyelination
100%
In Vivo Assessment
100%
Recombinant Human
53%
Myelination
46%
Cuprizone
46%
Growth Arrest-specific Gene 6 (Gas6)
38%
Corpus Callosum
23%
Cuprizone Model
15%
Direct Administration
15%
Multiple Sclerosis
15%
Specific Aims
15%
K-dependent
7%
PI3K/AKT Signaling
7%
Inflammation
7%
Central Nervous System Development
7%
Spinal Cord Injury
7%
Induced Cell Death
7%
Recovery Phase
7%
Public Health
7%
Cell Loss
7%
Growth Factor Withdrawal
7%
Signal Process
7%
AKT Pathway
7%
Central Nervous System
7%
Phosphoinositide 3-kinase (PI3K)
7%
Minipump
7%
Phase Following
7%
Exogenous Growth
7%
Survival Pathways
7%
Oligodendrocyte Cells
7%
Decoy
7%
Complementary DNA (cDNA)
7%
Tyrosine Kinase Family
7%
Demyelinating Disease
7%
Nervous System Maturation
7%
Axon
7%
Central Nervous System Diseases
7%
Receptor Tyrosine Kinase
7%
Microarray Assay
7%
Vitamin K
7%
Translational Research
7%
Oligodendrocyte Maturation
7%
Demyelinating
7%
AXL Receptor
7%
Higher Brain Dysfunction
7%
Human Growth
7%
Wild Mice
7%
Cell Death
7%
Gestational Week
7%
Human Fetal
7%
Mouse Model
7%
All Ages
7%
Neuroscience
Remyelinization
100%
In Vivo
100%
Oligodendrocyte
100%
Myelinogenesis
40%
Growth Arrest Specific Protein 6
33%
Corpus Callosum
20%
Phosphoinositide 3-Kinase
13%
Central Nervous System
13%
Multiple Sclerosis
13%
Cell Death
13%
Receptor
13%
Neurogenesis
6%
Receptor Tyrosine Kinase
6%
Growth Factor
6%
Vitamin K
6%
Brain Function
6%
Cell Signaling
6%
Cell Loss
6%
Spinal Cord Injury
6%
Axon
6%
C57BL 6 Mouse
6%
Demyelinating Disease
6%
Protein Kinase B
6%
Akt Signaling
6%